27.12.2012 Views

12th Congress of the European Hematology ... - Haematologica

12th Congress of the European Hematology ... - Haematologica

12th Congress of the European Hematology ... - Haematologica

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

0206<br />

POTENTIAL ROLE OF CMV IN THE ONTOGENY OF MONOCLONAL TCRαβ + /CD4 + T-LARGE<br />

GRANULAR LYMPHOCYTE [LGL] LYMPHOCYTOSIS<br />

R.C. Arancha, 1 A.C. Garcia-Montero, 1 J. Almeida Parra, 1<br />

P. Barcena Carrasco, 1 S. Muñoz-Criado, 1 F. Ruiz-Cabello, 2 A. Orfao 1<br />

1 Salamanca University SALAMANCA; 2 Virgen de las Nieves Hospital,<br />

GRANADA, Spain<br />

Background. Patients with TCR-Vβ13.1 + /CD4 + T-LGL lymphocytosis<br />

display a common HLA-DRB1*0701 genotype and express identical<br />

motifs in <strong>the</strong> CDR3-TCR-Vβ sequence, suggesting an antigen-driven<br />

chronic T-cell stimulation origin for this particular disease. 1 Interestingly,<br />

peripheral blood [PB] CMV-specific CD4 + T-cells from healthy adults<br />

are mostly antigen-experienced cytotoxic T-cells, which show a marked<br />

bias <strong>of</strong> <strong>the</strong> TCRVβ repertoire associated with certain HLA genotypes. 2<br />

Of note, <strong>the</strong> expansion <strong>of</strong> CMV-specific TCR-Vβ13.1 + CD4 + T-cells was<br />

associated with <strong>the</strong> HLA-DRB1*0701 allele. Thus, CMV would be a<br />

good candidate to play a role in <strong>the</strong> ontogeny <strong>of</strong> monoclonal<br />

TCRαβ + /CD4 + T-LGL lymphocytosis. Aims. To identify and characterize<br />

<strong>the</strong> CMV-specific clonal CD4 + T-cells from patients with different T-cell<br />

chronic lymphoproliferative disorders [CLPD]. Methods. PB samples from<br />

patients with monoclonal TCRαβ + /CD4 + T-LGL lymphocytosis [n=12],<br />

TCRαβ + /CD8 + LGL leukemias [n=2], TCRγδ + LGL leukemias [n=4] and<br />

o<strong>the</strong>r CD4 + T-CLPD than LGL [n=9], were stimulated for 6h with both<br />

CMV and EBV whole lysates. Identification <strong>of</strong> virus-specific CD4 + T-cells<br />

was assessed by flow cytometry, through <strong>the</strong> detection <strong>of</strong> surface TNFα<br />

on secreting cells. Soluble levels <strong>of</strong> IFNγ, TNFα, LTα, GM-CSF, IL-2, IL-<br />

3, IL-4, IL-5, IL-6, IL-9, IL-10, IL-12 and IL-13 in culture supernatants<br />

were quantified using <strong>the</strong> Cytometric Bead Array(TM) system [BDB].<br />

Surface detection <strong>of</strong> CD69 and CD25 as well as intracytoplasmic detection<br />

<strong>of</strong> IFNγ in CD4 + T-cells were both performed in TCRαβ + /CD4 + T-<br />

LGL patients, to evaluate CMV and EBV-specific responses after longer<br />

periods <strong>of</strong> stimulation [24-48h]. Results. Most patients [92%] were found<br />

to be CMV- and EBV-seropositive. However, <strong>the</strong> percentage <strong>of</strong> patients<br />

with CMV-specific CD4 + /TNFα + T-cells was significantly higher in<br />

TCRαβ + /CD4 + T-LGL lymphocytosis [83%] than in ei<strong>the</strong>r non-CD4 + /T-<br />

LGL leukemias [17%] or non-LGL/CD4 + T-CLPD [22%]. Fur<strong>the</strong>rmore,<br />

<strong>the</strong> former cases produced larger amounts <strong>of</strong> both IFNγ [p

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!